Start-Up Profile: Aileron Therapeutics

Two-year old firm is developing novel peptide stapling technologies; potential initial therapeutic targets include hematological cancers.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet